Analyst Reco. bioMérieux

Equities

BIM

FR0013280286

Medical Equipment, Supplies & Distribution

Real-time Euronext Paris Other stock markets 14:50:45 17/02/2026 GMT			5-day change	1st Jan Change
92.95 ^EUR	+0.81%		-1.48%	-15.73%

02-02	Oddo BHF Voices Concerns Over Currency Impact and Weaker Flu Season for bioMérieux
01-22	Interparfums, Michelin, Société Générale, Ubisoft... Stocks to Watch Today in Paris

Analyst Reco.

02-02	Oddo BHF Voices Concerns Over Currency Impact and Weaker Flu Season for bioMérieux
01-20	TP ICAP Midcap Upgrades bioMérieux to Buy	MT
11-10	UBS Maintains Buy Rating on BioMérieux, Confirms Price Target
11-05	Analysts Maintain Buy Ratings on bioMérieux After Q3 Results
11-05	Invest Securities Upgrades bioMérieux to Buy	MT
11-05	BioMérieux: Invest Securities upgrades stock after quarterly results
11-04	Biomérieux Q3 earnings miss prompts softer 2025 guidance
11-04	Stifel remains bullish on BioMérieux after trading update.
22/10/25	CIC Market Solutions Upgrades bioMérieux to Buy, Boosts PT	MT
11/09/25	BioMérieux: UBS Raises Price Target
11/09/25	BioMérieux: UBS raises target price
05/09/25	BioMérieux: Invest Securities Downgrades Rating to Neutral
05/09/25	BioMérieux: Invest Securities downgrades stock
05/09/25	Invest Securities Downgrades bioMérieux to Neutral, Lowers PT	MT
04/09/25	Gilbert Dupont Downgrades bioMérieux to Add	MT
04/09/25	BioMerieux: The H1 results are promising, confirming the attractiveness of market dynamics
04/09/25	BioMérieux: Oddo BHF confirms rating after new forecasts
04/09/25	BioMérieux: Stifel maintains buy rating
27/08/25	JPMorgan Initiates bioMérieux with Neutral Rating	MT
26/08/25	Morgan Stanley Downgrades bioMérieux to Equalweight, Trims PT	MT
15/07/25	AlphaValue/Baader Europe Ups BioMérieux Price Target	MT
14/07/25	BioMérieux: AlphaValue raises target price
11/07/25	BioMerieux: Attractiveness reinforced
07/05/25	RBC Capital Downgrades bioMérieux to Sector Perform, Trims PT	MT
07/05/25	BioMérieux: RBC downgrades stock

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Filters

Headlines

Biomérieux Q3 earnings miss prompts softer 2025 guidance

November 04, 2025 at 07:51 pm